Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Houhong Zhou

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cell Death & Disease|June 13, 2022
Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3Bing Lu, Jiatian Wei, Houhong Zhou, et al.
Frontiers in Pharmacology|November 17, 2022
AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinomaHouhong Zhou, Lei Zhang, Weihan Luo, et al.
Frontiers in Oncology|May 17, 2021
The Efficacy of Combined Cisplatin and Nanoparticle Albumin-Bound Paclitaxel in a Stage IV Pancreatic Squamous Cell Carcinoma Patient With a Somatic <i>BRCA2</i> Mutation: A Case ReportXiaozhun Huang, Chunling Wang, Teng Ma, et al.
Theranostics|January 2, 2024
Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapyDongdong Tang, Yang Yan, Yangyang Li, et al.
Cancer Research|March 20, 2023
The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune ResponseLei Zhang, Yuqing Li, Lingli Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2024
Bacterial outer membrane vesicle nanorobotSongsong Tang, Daitian Tang, Houhong Zhou, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cell Death & Disease|June 13, 2022
Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3Bing Lu, Jiatian Wei, Houhong Zhou, et al.
Frontiers in Pharmacology|November 17, 2022
AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinomaHouhong Zhou, Lei Zhang, Weihan Luo, et al.
Frontiers in Oncology|May 17, 2021
The Efficacy of Combined Cisplatin and Nanoparticle Albumin-Bound Paclitaxel in a Stage IV Pancreatic Squamous Cell Carcinoma Patient With a Somatic <i>BRCA2</i> Mutation: A Case ReportXiaozhun Huang, Chunling Wang, Teng Ma, et al.
Theranostics|January 2, 2024
Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapyDongdong Tang, Yang Yan, Yangyang Li, et al.
Cancer Research|March 20, 2023
The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune ResponseLei Zhang, Yuqing Li, Lingli Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2024
Bacterial outer membrane vesicle nanorobotSongsong Tang, Daitian Tang, Houhong Zhou, et al.
Pageof 1